Shin Wonseon, Choe Yeon Hyeon, Kim Sung Mok, Song In-Young, Kim Sam Soo
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Acta Radiol. 2014 Apr;55(3):273-8. doi: 10.1177/0284185113496561. Epub 2013 Aug 7.
Cardiac myxomas are sources of systemic embolism. Currently a large volume of chest CT and calcium-scoring CT scans are performed without contrast injection.
To evaluate the diagnostic capability of non-contrast CT covering heart in detecting cardiac myxomas.
This retrospective study included 36 non-contrast CT scans of 36 consecutive patients (16 men, 20 women) who underwent CT scan before surgery for left atrial myxomas and 20 patients without myxoma as a control group. Two independent readers who were blinded to medical information reviewed non-contrast CT scans of 36 patients with cardiac myxomas and 20 scans in the control group patients. They determined the presence of lesions suspicious of myxomas using a five-point scale. The other reader measured attenuation number in the non-calcific areas of the tumors and sizes of the masses on the non-contrast CT images.
The average attenuation of cardiac myxoma (22.5 Hounsfield units [HU]; range, 8.9-32.9 HU) and adjacent unopacified blood (44.6 HU; range, 31.5-57 HU) were significantly different (P < 0.001). Twelve cardiac myxomas (31.6%) had internal calcification and all of them were detected by both of readers. Cardiac myxomas were measured smaller on non-contrast CT (mean, 3.5 cm; range, 1.1-9.7 cm) than on pathologic specimens (mean, 4.1 cm, 1.4-10.0 cm) (P < 0.001). Considering grade 3-5 on a five-grade scale as the detectability, the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of non-contrast CT in detecting cardiac myxomas were 88.8%/86.1%, 95.0%/100%, 96.9%/100%, 82.6%/80.0%, and 91.1%/91.1%, by reader 1 and reader 2, respectively and there was good inter-observer reliability (kappa value = 0.92, P = 0.157).
Non-contrast CT scan is useful for detecting cardiac myxomas. Therefore, radiologists should be familiar with imaging findings of cardiac myxomas on non-contrast CT.
心脏黏液瘤是系统性栓塞的来源。目前,大量的胸部CT和钙化积分CT扫描在未注射对比剂的情况下进行。
评估未注射对比剂的心脏CT在检测心脏黏液瘤方面的诊断能力。
这项回顾性研究纳入了36例连续患者(16例男性,20例女性)的36次未注射对比剂的CT扫描,这些患者在接受左心房黏液瘤手术前进行了CT扫描,另外纳入20例无黏液瘤的患者作为对照组。两名对医疗信息不知情的独立阅片者对36例心脏黏液瘤患者的未注射对比剂的CT扫描以及对照组患者的20次扫描进行了评估。他们使用五分制量表确定是否存在可疑黏液瘤病变。另一位阅片者测量了肿瘤非钙化区域的衰减值以及未注射对比剂的CT图像上肿块的大小。
心脏黏液瘤的平均衰减值(22.5亨氏单位[HU];范围8.9 - 32.9 HU)与相邻未显影血液的平均衰减值(44.6 HU;范围31.5 - 57 HU)有显著差异(P < 0.001)。12个心脏黏液瘤(31.6%)有内部钙化,两位阅片者均检测到了所有这些钙化。未注射对比剂的CT测量的心脏黏液瘤大小(平均3.5 cm;范围1.1 - 9.7 cm)小于病理标本测量的大小(平均4.1 cm,1.4 - 10.0 cm)(P < 0.001)。以五分制量表中的3 - 5级为可检测性标准,阅片者1和阅片者2对未注射对比剂的CT检测心脏黏液瘤的敏感性、特异性、阳性预测值、阴性预测值和诊断准确性分别为88.8%/86.1%、95.0%/100%、96.9%/100%、82.6%/80.0%和91.1%/91.1%,观察者间可靠性良好(kappa值 = 0.92,P = 0.157)。
未注射对比剂的CT扫描对检测心脏黏液瘤有用。因此,放射科医生应熟悉未注射对比剂的CT上心脏黏液瘤的影像学表现。